T1	AdverseReaction 379 401	Retinal vein occlusion
T2	AdverseReaction 411 436	Interstitial lung disease
T3	AdverseReaction 451 471;487 500	primary malignancies non-cutaneous
T4	AdverseReaction 451 482	primary malignancies, cutaneous
T5	AdverseReaction 822 850	Increased cell proliferation
T6	AdverseReaction 918 936	hemorrhagic events
T7	Severity 912 917	Major
T8	AdverseReaction 1095 1115	Deep vein thrombosis
T9	AdverseReaction 1120 1138	pulmonary embolism
T10	AdverseReaction 1237 1251	Cardiomyopathy
T11	AdverseReaction 1420 1437	Ocular Toxicities
T12	AdverseReaction 1580 1587	pyrexia
T13	AdverseReaction 1681 1694	Skin Toxicity
T14	Severity 1673 1680	Serious
T15	Factor 502 505	can
T17	Factor 937 940	can
T18	Factor 1139 1142	can
T19	AdverseReaction 1900 1913	Hyperglycemia
T20	AdverseReaction 2018 2062	Glucose-6-Phosphate Dehydrogenase Deficiency
T21	AdverseReaction 2152 2162	fetal harm
T22	Factor 2142 2145	Can
T23	AdverseReaction 2435 2466	primary malignancies, cutaneous
T24	Factor 2486 2489	can
T25	AdverseReaction 2435 2455;2471 2484	primary malignancies non-cutaneous
T26	AdverseReaction 2670 2703	cutaneous squamous cell carcinoma
T27	AdverseReaction 2705 2720	keratoacanthoma
T28	AdverseReaction 2726 2734	melanoma
T29	AdverseReaction 2823 2843	basal cell carcinoma
T30	AdverseReaction 2863 2897	cutaneous squamous cell carcinomas
T31	AdverseReaction 2902 2918	keratoacanthomas
T32	AdverseReaction 2920 2925	cuSCC
T33	AdverseReaction 3106 3111	cuSCC
T34	AdverseReaction 3146 3151	cuSCC
T35	AdverseReaction 3224 3229	cuSCC
T36	AdverseReaction 3271 3276	cuSCC
T37	AdverseReaction 3367 3372	cuSCC
T38	AdverseReaction 3388 3393	cuSCC
T39	AdverseReaction 3444 3471	primary malignant melanomas
T43	AdverseReaction 3641 3661	basal cell carcinoma
T44	AdverseReaction 3919 3939	basal cell carcinoma
T45	AdverseReaction 4099 4132	Cutaneous squamous cell carcinoma
T46	AdverseReaction 4134 4137	SCC
T47	AdverseReaction 4150 4165	keratoacanthoma
T48	AdverseReaction 4336 4341	cuSCC
T49	AdverseReaction 4466 4482	primary melanoma
T50	AdverseReaction 5107 5119	malignancies
T51	Factor 5065 5068	may
T52	AdverseReaction 5296 5322	non-cutaneous malignancies
T53	AdverseReaction 5340 5388	KRAS mutation-positive pancreatic adenocarcinoma
T54	AdverseReaction 5398 5451	recurrent NRAS mutation-positive colorectal carcinoma
T55	AdverseReaction 5461 5484	head and neck carcinoma
T56	AdverseReaction 5498 5510	glioblastoma
T57	AdverseReaction 6002 6030	increased cell proliferation
T59	AdverseReaction 6325 6336	Hemorrhages
T60	AdverseReaction 6354 6365	hemorrhages
T61	Severity 6348 6353	major
T62	AdverseReaction 6377 6397	symptomatic bleeding
T63	Factor 6427 6430	can
T64	AdverseReaction 6620 6637	hemorrhagic event
T65	AdverseReaction 6802 6820	hemorrhagic events
T66	Severity 6796 6801	major
T67	AdverseReaction 6824 6836;6848 6858	intracranial hemorrhage
T68	AdverseReaction 6840 6858	gastric hemorrhage
T69	AdverseReaction 7025 7048	Intracranial hemorrhage
T70	AdverseReaction 7053 7058	fatal
T71	AdverseReaction 7535 7557	Venous thromboembolism
T72	Factor 7558 7561	can
T73	AdverseReaction 7734 7756	deep venous thrombosis
T74	AdverseReaction 7758 7761	DVT
T75	AdverseReaction 7767 7785	pulmonary embolism
T76	AdverseReaction 7787 7789	PE
T77	AdverseReaction 7946 7964	Pulmonary embolism
T78	AdverseReaction 7969 7974	fatal
T79	AdverseReaction 8526 8540	Cardiomyopathy
T80	Factor 8541 8544	can
T81	AdverseReaction 8719 8733	cardiomyopathy
T82	AdverseReaction 8914 8928	cardiomyopathy
T83	AdverseReaction 9031 9045	Cardiomyopathy
T84	AdverseReaction 9182 9196	cardiomyopathy
T85	AdverseReaction 9426 9440	cardiomyopathy
T86	AdverseReaction 9442 9458	decrease in LVEF
T87	AdverseReaction 9510 9535	absolute decrease in LVEF
T88	Severity 9538 9556	10% below baseline
T89	AdverseReaction 9586 9602	decrease in LVEF
T90	Severity 9465 9501	institutional lower limits of normal
T91	Severity 9609 9645	institutional lower limits of normal
T92	AdverseReaction 9654 9679	absolute decrease in LVEF
T93	Severity 9685 9703	20% below baseline
T94	AdverseReaction 10510 10548	Retinal pigment epithelial detachments
T95	AdverseReaction 10550 10554	RPED
T96	Factor 10556 10559	can
T97	AdverseReaction 10991 10995	RPED
T98	AdverseReaction 11188 11192	RPED
T99	AdverseReaction 11741 11748	Uveitis
T100	AdverseReaction 11753 11759	iritis
T101	Factor 11760 11763	can
T102	AdverseReaction 11870 11877	Uveitis
T103	AdverseReaction 11889 11895	iritis
T104	AdverseReaction 11976 11983	uveitis
T105	AdverseReaction 12516 12533	febrile reactions
T106	Severity 12508 12515	Serious
T107	AdverseReaction 12538 12543	fever
T108	AdverseReaction 12575 12586	hypotension
T109	AdverseReaction 12588 12594	rigors
T110	AdverseReaction 12598 12604	chills
T111	AdverseReaction 12606 12617	dehydration
T112	AdverseReaction 12622 12635	renal failure
T113	Factor 12637 12640	can
T114	AdverseReaction 12954 12959	fever
T115	Severity 12961 12968	serious
T116	AdverseReaction 13145 13150	fever
T117	AdverseReaction 13228 13233	fever
T118	AdverseReaction 13277 13294	febrile reactions
T119	Severity 13269 13276	Serious
T120	AdverseReaction 13299 13304	fever
T121	AdverseReaction 13336 13347	hypotension
T122	AdverseReaction 13349 13355	rigors
T123	AdverseReaction 13359 13365	chills
T124	AdverseReaction 13518 13523	fever
T125	Severity 13525 13532	serious
T126	AdverseReaction 13708 13725	febrile reactions
T127	Severity 13700 13707	Serious
T128	AdverseReaction 13730 13735	fever
T129	AdverseReaction 13767 13778	hypotension
T130	AdverseReaction 13780 13786	rigors
T131	AdverseReaction 13790 13796	chills
T132	AdverseReaction 13963 13968	Fever
T133	AdverseReaction 13990 13996	chills
T134	AdverseReaction 13997 14003	rigors
T135	AdverseReaction 14020 14031	dehydration
T136	AdverseReaction 14046 14059	renal failure
T137	AdverseReaction 14078 14085	syncope
T138	AdverseReaction 14232 14237	fever
T139	AdverseReaction 14348 14353	fever
T140	AdverseReaction 14554 14561	pyrexia
T141	AdverseReaction 15166 15179	skin toxicity
T142	Severity 15158 15165	Serious
T143	Factor 15180 15183	can
T144	AdverseReaction 15379 15392	skin toxicity
T145	AdverseReaction 15585 15598	skin toxicity
T146	AdverseReaction 15732 15745	skin toxicity
T147	AdverseReaction 15982 15995	skin toxicity
T148	AdverseReaction 16000 16032	secondary infections of the skin
T149	Severity 15975 15981	severe
T150	AdverseReaction 16465 16478	Hyperglycemia
T151	Factor 16479 16482	can
T152	AdverseReaction 16737 16750	hyperglycemia
T153	Severity 16729 16736	Grade 3
T154	AdverseReaction 16926 16939	hyperglycemia
T155	Severity 16918 16925	Grade 3
T156	AdverseReaction 17614 17630	hemolytic anemia
T157	Factor 17606 17610	risk
T158	AdverseReaction 17869 17879	fetal harm
T159	Factor 17859 17862	can
T160	AdverseReaction 17934 17945	teratogenic
T161	AdverseReaction 17950 17961	embryotoxic
T162	Animal 17965 17969	rats
T163	DrugClass 866 881	BRAF inhibitors
T164	DrugClass 6076 6091	BRAF inhibitors
T165	AdverseReaction 10715 10734	Retinal detachments
T166	AdverseReaction 12770 12777	pyrexia
T167	AdverseReaction 778 820	Tumor Promotion in BRAF Wild-Type Melanoma
T168	AdverseReaction 900 910	Hemorrhage
T169	AdverseReaction 1071 1093	Venous Thromboembolism
T170	AdverseReaction 1535 1552	Febrile Reactions
T171	Severity 1527 1534	Serious
T172	AdverseReaction 2120 2140	Embryofetal Toxicity
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3 Hypothetical:E15
E4	AdverseReaction:T4 Hypothetical:E15
E5	AdverseReaction:T5 Hypothetical:E165
E6	AdverseReaction:T6 Effect:E7 Hypothetical:E17
E7	Severity:T7
E8	AdverseReaction:T8 Hypothetical:E18
E9	AdverseReaction:T9 Hypothetical:E18
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13 Effect:E14
E14	Severity:T14
E15	Factor:T15
E17	Factor:T17
E18	Factor:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21 Hypothetical:E22
E22	Factor:T22
E23	AdverseReaction:T23 Hypothetical:E24
E24	Factor:T24
E25	AdverseReaction:T25 Hypothetical:E24
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37
E38	AdverseReaction:T38
E39	AdverseReaction:T39
E43	AdverseReaction:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46
E47	AdverseReaction:T47
E48	AdverseReaction:T48
E49	AdverseReaction:T49
E50	AdverseReaction:T50 Hypothetical:E51
E51	Factor:T51
E52	AdverseReaction:T52
E53	AdverseReaction:T53
E54	AdverseReaction:T54
E55	AdverseReaction:T55
E56	AdverseReaction:T56
E57	AdverseReaction:T57 Hypothetical:E166
E59	AdverseReaction:T59 Hypothetical:E63
E60	AdverseReaction:T60 Effect:E61 Hypothetical:E63
E61	Severity:T61
E62	AdverseReaction:T62 Hypothetical:E63
E63	Factor:T63
E64	AdverseReaction:T64
E65	AdverseReaction:T65 Effect:E66
E66	Severity:T66
E67	AdverseReaction:T67
E68	AdverseReaction:T68
E69	AdverseReaction:T69
E70	AdverseReaction:T70
E71	AdverseReaction:T71 Hypothetical:E72
E72	Factor:T72
E73	AdverseReaction:T73
E74	AdverseReaction:T74
E75	AdverseReaction:T75
E76	AdverseReaction:T76
E77	AdverseReaction:T77
E78	AdverseReaction:T78
E79	AdverseReaction:T79 Hypothetical:E80
E80	Factor:T80
E81	AdverseReaction:T81
E82	AdverseReaction:T82
E83	AdverseReaction:T83
E84	AdverseReaction:T84
E85	AdverseReaction:T85
E86	AdverseReaction:T86 Effect:E90
E87	AdverseReaction:T87 Effect:E88
E88	Severity:T88
E89	AdverseReaction:T89 Effect:E91
E90	Severity:T90
E91	Severity:T91
E92	AdverseReaction:T92 Effect:E93
E93	Severity:T93
E94	AdverseReaction:T94 Hypothetical:E96
E95	AdverseReaction:T95 Hypothetical:E96
E96	Factor:T96
E97	AdverseReaction:T97
E98	AdverseReaction:T98
E99	AdverseReaction:T99 Hypothetical:E101
E100	AdverseReaction:T100 Hypothetical:E101
E101	Factor:T101
E102	AdverseReaction:T102
E103	AdverseReaction:T103
E104	AdverseReaction:T104
E105	AdverseReaction:T105 Effect:E106 Hypothetical:E113
E106	Severity:T106
E107	AdverseReaction:T107 Hypothetical:E113
E108	AdverseReaction:T108 Hypothetical:E113
E109	AdverseReaction:T109 Hypothetical:E113
E110	AdverseReaction:T110 Hypothetical:E113
E111	AdverseReaction:T111 Hypothetical:E113
E112	AdverseReaction:T112 Hypothetical:E113
E113	Factor:T113
E114	AdverseReaction:T114
E115	AdverseReaction:T114 Effect:E116
E116	Severity:T115
E117	AdverseReaction:T116
E118	AdverseReaction:T117
E119	AdverseReaction:T118 Effect:E120
E120	Severity:T119
E121	AdverseReaction:T120
E122	AdverseReaction:T121
E123	AdverseReaction:T122
E124	AdverseReaction:T123
E125	AdverseReaction:T124
E126	AdverseReaction:T124 Effect:E127
E127	Severity:T125
E128	AdverseReaction:T126 Effect:E129
E129	Severity:T127
E130	AdverseReaction:T128
E131	AdverseReaction:T129
E132	AdverseReaction:T130
E133	AdverseReaction:T131
E134	AdverseReaction:T132
E135	AdverseReaction:T133
E136	AdverseReaction:T134
E137	AdverseReaction:T135
E138	AdverseReaction:T136
E139	AdverseReaction:T137
E140	AdverseReaction:T138
E141	AdverseReaction:T139
E142	AdverseReaction:T140
E143	AdverseReaction:T141 Effect:E144 Hypothetical:E145
E144	Severity:T142
E145	Factor:T143
E146	AdverseReaction:T144
E147	AdverseReaction:T145
E148	AdverseReaction:T146
E149	AdverseReaction:T147 Effect:E151
E150	AdverseReaction:T148
E151	Severity:T149
E152	AdverseReaction:T150 Hypothetical:E153
E153	Factor:T151
E154	AdverseReaction:T152 Effect:E155
E155	Severity:T153
E156	AdverseReaction:T154 Effect:E157
E157	Severity:T155
E158	AdverseReaction:T156 Hypothetical:E159
E159	Factor:T157
E160	AdverseReaction:T158 Hypothetical:E161
E161	Factor:T159
E162	AdverseReaction:T160 Hypothetical:E164
E163	AdverseReaction:T161 Hypothetical:E164
E164	Animal:T162
E165	DrugClass:T163
E166	DrugClass:T164
E167	AdverseReaction:T165
E168	AdverseReaction:T166
E169	AdverseReaction:T167
E170	AdverseReaction:T168
E171	AdverseReaction:T169
E172	AdverseReaction:T170 Effect:E173
E173	Severity:T171
E174	AdverseReaction:T172
A1	CUI E1 C0035328
A2	UMLS-Preferred-Name E1 Retinal Vein Occlusion
A3	MEDDRA-PT E1 Retinal vein occlusion
A4	MEDDRA-PT-ID E1 10038907
A5	CUI E2 C0206062
A6	UMLS-Preferred-Name E2 Lung Diseases, Interstitial
A7	MEDDRA-PT E2 Interstitial lung disease
A8	MEDDRA-PT-ID E2 10022611
A9	CUI E3 C0865017
A10	UMLS-Preferred-Name E3 Generalized malignancy, primary
A11	MEDDRA-PT E3 Neoplasm malignant
A12	MEDDRA-PT-ID E3 10028997
A13	CUI E4 C0007114
A14	UMLS-Preferred-Name E4 Malignant neoplasm of skin
A15	MEDDRA-PT E4 Skin cancer
A16	MEDDRA-PT-ID E4 10040808
A17	LLT E4 Skin neoplasm malignant
A18	LLT-ID E4 10040895
A19	CUI E5 C0020507
A20	UMLS-Preferred-Name E5 Hyperplasia
A21	MEDDRA-PT E5 Hyperplasia
A22	MEDDRA-PT-ID E5 10020718
A23	CUI E6 C0019080
A24	UMLS-Preferred-Name E6 Hemorrhage
A25	MEDDRA-PT E6 Haemorrhage
A26	MEDDRA-PT-ID E6 10055798
A27	LLT E6 Hemorrhage
A28	LLT-ID E6 10019524
A29	CUI E8 C0149871
A30	UMLS-Preferred-Name E8 Deep Vein Thrombosis
A31	MEDDRA-PT E8 Deep vein thrombosis
A32	MEDDRA-PT-ID E8 10051055
A33	CUI E9 C0034065
A34	UMLS-Preferred-Name E9 Pulmonary Embolism
A35	MEDDRA-PT E9 Pulmonary embolism
A36	MEDDRA-PT-ID E9 10037377
A37	CUI E10 C0878544
A38	UMLS-Preferred-Name E10 Cardiomyopathies
A39	MEDDRA-PT E10 Cardiomyopathy
A40	MEDDRA-PT-ID E10 10007636
A41	CUI E11 C1262036
A42	UMLS-Preferred-Name E11 Ocular toxicity
A43	MEDDRA-PT E11 Ocular toxicity
A44	MEDDRA-PT-ID E11 10061137
A45	CUI E12 C0015967
A46	UMLS-Preferred-Name E12 Fever
A47	MEDDRA-PT E12 Pyrexia
A48	MEDDRA-PT-ID E12 10037660
A49	CUI E13 C1167791
A50	UMLS-Preferred-Name E13 Skin toxicity
A51	MEDDRA-PT E13 Skin toxicity
A52	MEDDRA-PT-ID E13 10059516
A53	CUI E19 C0020456
A54	UMLS-Preferred-Name E19 Hyperglycemia
A55	MEDDRA-PT E19 Hyperglycaemia
A56	MEDDRA-PT-ID E19 10020635
A57	LLT E19 Hyperglycemia
A58	LLT-ID E19 10020639
A59	CUI E20 C2939465
A60	UMLS-Preferred-Name E20 Deficiency of glucose-6-phosphate dehydrogenase
A61	MEDDRA-PT E20 Glucose-6-phosphate dehydrogenase deficiency
A62	MEDDRA-PT-ID E20 10018444
A63	CUI E21 C0854268
A64	UMLS-Preferred-Name E21 Foetal damage
A65	MEDDRA-PT E21 Foetal damage
A66	MEDDRA-PT-ID E21 10016852
A67	LLT E21 Fetal damage
A68	LLT-ID E21 10054743
A69	CUI E23 C0007114
A70	UMLS-Preferred-Name E23 Malignant neoplasm of skin
A71	MEDDRA-PT E23 Skin cancer
A72	MEDDRA-PT-ID E23 10040808
A73	LLT E23 Skin neoplasm malignant
A74	LLT-ID E23 10040895
A75	CUI E25 C0865017
A76	UMLS-Preferred-Name E25 Generalized malignancy, primary
A77	MEDDRA-PT E25 Neoplasm malignant
A78	MEDDRA-PT-ID E25 10028997
A79	CUI E26 C0553723
A80	UMLS-Preferred-Name E26 Squamous cell carcinoma of skin
A81	MEDDRA-PT E26 Squamous cell carcinoma of skin
A82	MEDDRA-PT-ID E26 10041834
A83	CUI E27 C0022572
A84	UMLS-Preferred-Name E27 keratoacanthoma
A85	MEDDRA-PT E27 Keratoacanthoma
A86	MEDDRA-PT-ID E27 10023347
A87	CUI E28 C0025202
A88	UMLS-Preferred-Name E28 melanoma
A89	MEDDRA-PT E28 Malignant melanoma
A90	MEDDRA-PT-ID E28 10025650
A91	LLT E28 Melanoma
A92	LLT-ID E28 10053571
A93	CUI E29 C0007117
A94	UMLS-Preferred-Name E29 Basal cell carcinoma
A95	MEDDRA-PT E29 Basal cell carcinoma
A96	MEDDRA-PT-ID E29 10004146
A97	CUI E30 C0553723
A98	UMLS-Preferred-Name E30 Squamous cell carcinoma of skin
A99	MEDDRA-PT E30 Squamous cell carcinoma of skin
A100	MEDDRA-PT-ID E30 10041834
A101	CUI E31 C0022572
A102	UMLS-Preferred-Name E31 keratoacanthoma
A103	MEDDRA-PT E31 Keratoacanthoma
A104	MEDDRA-PT-ID E31 10023347
A105	CUI E32 C0553723
A106	UMLS-Preferred-Name E32 Squamous cell carcinoma of skin
A107	MEDDRA-PT E32 Squamous cell carcinoma of skin
A108	MEDDRA-PT-ID E32 10041834
A109	CUI E33 C0553723
A110	UMLS-Preferred-Name E33 Squamous cell carcinoma of skin
A111	MEDDRA-PT E33 Squamous cell carcinoma of skin
A112	MEDDRA-PT-ID E33 10041834
A113	CUI E34 C0553723
A114	UMLS-Preferred-Name E34 Squamous cell carcinoma of skin
A115	MEDDRA-PT E34 Squamous cell carcinoma of skin
A116	MEDDRA-PT-ID E34 10041834
A117	CUI E35 C0553723
A118	UMLS-Preferred-Name E35 Squamous cell carcinoma of skin
A119	MEDDRA-PT E35 Squamous cell carcinoma of skin
A120	MEDDRA-PT-ID E35 10041834
A121	CUI E36 C0553723
A122	UMLS-Preferred-Name E36 Squamous cell carcinoma of skin
A123	MEDDRA-PT E36 Squamous cell carcinoma of skin
A124	MEDDRA-PT-ID E36 10041834
A125	CUI E37 C0553723
A126	UMLS-Preferred-Name E37 Squamous cell carcinoma of skin
A127	MEDDRA-PT E37 Squamous cell carcinoma of skin
A128	MEDDRA-PT-ID E37 10041834
A129	CUI E38 C0553723
A130	UMLS-Preferred-Name E38 Squamous cell carcinoma of skin
A131	MEDDRA-PT E38 Squamous cell carcinoma of skin
A132	MEDDRA-PT-ID E38 10041834
A133	CUI E39 C0025202
A134	UMLS-Preferred-Name E39 melanoma
A135	MEDDRA-PT E39 Malignant melanoma
A136	MEDDRA-PT-ID E39 10025650
A137	CUI E43 C0007117
A138	UMLS-Preferred-Name E43 Basal cell carcinoma
A139	MEDDRA-PT E43 Basal cell carcinoma
A140	MEDDRA-PT-ID E43 10004146
A141	CUI E44 C0007117
A142	UMLS-Preferred-Name E44 Basal cell carcinoma
A143	MEDDRA-PT E44 Basal cell carcinoma
A144	MEDDRA-PT-ID E44 10004146
A145	CUI E45 C0553723
A146	UMLS-Preferred-Name E45 Squamous cell carcinoma of skin
A147	MEDDRA-PT E45 Squamous cell carcinoma of skin
A148	MEDDRA-PT-ID E45 10041834
A149	CUI E46 C0553723
A150	UMLS-Preferred-Name E46 Squamous cell carcinoma of skin
A151	MEDDRA-PT E46 Squamous cell carcinoma of skin
A152	MEDDRA-PT-ID E46 10041834
A153	CUI E47 C0022572
A154	UMLS-Preferred-Name E47 keratoacanthoma
A155	MEDDRA-PT E47 Keratoacanthoma
A156	MEDDRA-PT-ID E47 10023347
A157	CUI E48 C0553723
A158	UMLS-Preferred-Name E48 Squamous cell carcinoma of skin
A159	MEDDRA-PT E48 Squamous cell carcinoma of skin
A160	MEDDRA-PT-ID E48 10041834
A161	CUI E49 C0025202
A162	UMLS-Preferred-Name E49 melanoma
A163	MEDDRA-PT E49 Malignant melanoma
A164	MEDDRA-PT-ID E49 10025650
A165	LLT E49 Melanoma
A166	LLT-ID E49 10053571
A167	CUI E50 C0006826
A168	UMLS-Preferred-Name E50 Malignant Neoplasms
A169	MEDDRA-PT E50 Neoplasm malignant
A170	MEDDRA-PT-ID E50 10028997
A171	flag E52 underspecified
A172	CUI E52 C0006826
A173	UMLS-Preferred-Name E52 Malignant Neoplasms
A174	MEDDRA-PT E52 Neoplasm malignant
A175	MEDDRA-PT-ID E52 10028997
A176	flag E53 duplicate
A177	CUI E53 C2747837
A178	UMLS-Preferred-Name E53 KRAS mutation
A179	MEDDRA-PT E53 K-ras gene mutation
A180	MEDDRA-PT-ID E53 10069755
A181	LLT E53 KRAS mutation
A182	LLT-ID E53 10069759
A183	flag E54 underspecified
A184	CUI E54 C0009402
A185	UMLS-Preferred-Name E54 Colorectal Carcinoma
A186	MEDDRA-PT E54 Colorectal cancer
A187	MEDDRA-PT-ID E54 10061451
A188	LLT E54 Colorectal carcinoma
A189	LLT-ID E54 10010036
A190	flag E55 unmapped
A191	CUI E55 C3887461
A192	UMLS-Preferred-Name E55 Head and Neck Carcinoma
A193	CUI E56 C0017636
A194	UMLS-Preferred-Name E56 Glioblastoma
A195	MEDDRA-PT E56 Glioblastoma
A196	MEDDRA-PT-ID E56 10018336
A197	CUI E57 C0020507
A198	UMLS-Preferred-Name E57 Hyperplasia
A199	MEDDRA-PT E57 Hyperplasia
A200	MEDDRA-PT-ID E57 10020718
A201	CUI E59 C0019080
A202	UMLS-Preferred-Name E59 Hemorrhage
A203	MEDDRA-PT E59 Haemorrhage
A204	MEDDRA-PT-ID E59 10055798
A205	LLT E59 Hemorrhage
A206	LLT-ID E59 10019524
A207	CUI E60 C0019080
A208	UMLS-Preferred-Name E60 Hemorrhage
A209	MEDDRA-PT E60 Haemorrhage
A210	MEDDRA-PT-ID E60 10055798
A211	LLT E60 Hemorrhage
A212	LLT-ID E60 10019524
A213	flag E62 underspecified
A214	CUI E62 C0019080
A215	UMLS-Preferred-Name E62 Hemorrhage
A216	MEDDRA-PT E62 Haemorrhage
A217	MEDDRA-PT-ID E62 10055798
A218	LLT E62 Bleeding
A219	LLT-ID E62 10005103
A220	CUI E64 C0019080
A221	UMLS-Preferred-Name E64 Hemorrhage
A222	MEDDRA-PT E64 Haemorrhage
A223	MEDDRA-PT-ID E64 10055798
A224	LLT E64 Hemorrhage
A225	LLT-ID E64 10019524
A226	CUI E65 C0019080
A227	UMLS-Preferred-Name E65 Hemorrhage
A228	MEDDRA-PT E65 Haemorrhage
A229	MEDDRA-PT-ID E65 10055798
A230	LLT E65 Hemorrhage
A231	LLT-ID E65 10019524
A232	CUI E67 C0151699
A233	UMLS-Preferred-Name E67 Intracranial Hemorrhages
A234	MEDDRA-PT E67 Haemorrhage intracranial
A235	MEDDRA-PT-ID E67 10018985
A236	LLT E67 Intracranial hemorrhage
A237	LLT-ID E67 10022763
A238	CUI E68 C0235325
A239	UMLS-Preferred-Name E68 Gastric hemorrhage
A240	MEDDRA-PT E68 Gastric haemorrhage
A241	MEDDRA-PT-ID E68 10017788
A242	LLT E68 Gastric hemorrhage
A243	LLT-ID E68 10017789
A244	CUI E69 C0151699
A245	UMLS-Preferred-Name E69 Intracranial Hemorrhages
A246	MEDDRA-PT E69 Haemorrhage intracranial
A247	MEDDRA-PT-ID E69 10018985
A248	LLT E69 Intracranial hemorrhage
A249	LLT-ID E69 10022763
A250	CUI E70 C1306577
A251	UMLS-Preferred-Name E70 Death (finding)
A252	MEDDRA-PT E70 Death
A253	MEDDRA-PT-ID E70 10011906
A254	CUI E71 C1861172
A255	UMLS-Preferred-Name E71 Venous Thromboembolism
A256	MEDDRA-PT E71 Embolism venous
A257	MEDDRA-PT-ID E71 10014522
A258	LLT E71 Venous thromboembolism
A259	LLT-ID E71 10066899
A260	CUI E73 C0149871
A261	UMLS-Preferred-Name E73 Deep Vein Thrombosis
A262	MEDDRA-PT E73 Deep vein thrombosis
A263	MEDDRA-PT-ID E73 10051055
A264	LLT E73 Thrombosis venous deep
A265	LLT-ID E73 10043642
A266	CUI E74 C0149871
A267	UMLS-Preferred-Name E74 Deep Vein Thrombosis
A268	MEDDRA-PT E74 Deep vein thrombosis
A269	MEDDRA-PT-ID E74 10051055
A270	LLT E74 DVT
A271	LLT-ID E74 10013877
A272	CUI E75 C0034065
A273	UMLS-Preferred-Name E75 Pulmonary Embolism
A274	MEDDRA-PT E75 Pulmonary embolism
A275	MEDDRA-PT-ID E75 10037377
A276	CUI E76 C0034065
A277	UMLS-Preferred-Name E76 Pulmonary Embolism
A278	MEDDRA-PT E76 Pulmonary embolism
A279	MEDDRA-PT-ID E76 10037377
A280	CUI E77 C0034065
A281	UMLS-Preferred-Name E77 Pulmonary Embolism
A282	MEDDRA-PT E77 Pulmonary embolism
A283	MEDDRA-PT-ID E77 10037377
A284	CUI E78 C1306577
A285	UMLS-Preferred-Name E78 Death (finding)
A286	MEDDRA-PT E78 Death
A287	MEDDRA-PT-ID E78 10011906
A288	CUI E79 C0878544
A289	UMLS-Preferred-Name E79 Cardiomyopathies
A290	MEDDRA-PT E79 Cardiomyopathy
A291	MEDDRA-PT-ID E79 10007636
A292	CUI E81 C0878544
A293	UMLS-Preferred-Name E81 Cardiomyopathies
A294	MEDDRA-PT E81 Cardiomyopathy
A295	MEDDRA-PT-ID E81 10007636
A296	CUI E82 C0878544
A297	UMLS-Preferred-Name E82 Cardiomyopathies
A298	MEDDRA-PT E82 Cardiomyopathy
A299	MEDDRA-PT-ID E82 10007636
A300	CUI E83 C0878544
A301	UMLS-Preferred-Name E83 Cardiomyopathies
A302	MEDDRA-PT E83 Cardiomyopathy
A303	MEDDRA-PT-ID E83 10007636
A304	CUI E84 C0878544
A305	UMLS-Preferred-Name E84 Cardiomyopathies
A306	MEDDRA-PT E84 Cardiomyopathy
A307	MEDDRA-PT-ID E84 10007636
A308	CUI E85 C0878544
A309	UMLS-Preferred-Name E85 Cardiomyopathies
A310	MEDDRA-PT E85 Cardiomyopathy
A311	MEDDRA-PT-ID E85 10007636
A312	CUI E86 C1096403
A313	UMLS-Preferred-Name E86 Left ventricular ejection fraction decreased
A314	MEDDRA-PT E86 Ejection fraction decreased
A315	MEDDRA-PT-ID E86 10050528
A316	LLT E86 Left ventricular ejection fraction decreased
A317	LLT-ID E86 10053222
A318	CUI E87 C1096403
A319	UMLS-Preferred-Name E87 Left ventricular ejection fraction decreased
A320	MEDDRA-PT E87 Ejection fraction decreased
A321	MEDDRA-PT-ID E87 10050528
A322	LLT E87 Left ventricular ejection fraction decreased
A323	LLT-ID E87 10053222
A324	CUI E89 C1096403
A325	UMLS-Preferred-Name E89 Left ventricular ejection fraction decreased
A326	MEDDRA-PT E89 Ejection fraction decreased
A327	MEDDRA-PT-ID E89 10050528
A328	LLT E89 Left ventricular ejection fraction decreased
A329	LLT-ID E89 10053222
A330	CUI E92 C1096403
A331	UMLS-Preferred-Name E92 Left ventricular ejection fraction decreased
A332	MEDDRA-PT E92 Ejection fraction decreased
A333	MEDDRA-PT-ID E92 10050528
A334	LLT E92 Left ventricular ejection fraction decreased
A335	LLT-ID E92 10053222
A336	CUI E94 C0339546
A337	UMLS-Preferred-Name E94 Retinal Pigment Epithelial Detachment
A338	MEDDRA-PT E94 Detachment of retinal pigment epithelium
A339	MEDDRA-PT-ID E94 10052501
A340	CUI E95 C0339546
A341	UMLS-Preferred-Name E95 Retinal Pigment Epithelial Detachment
A342	MEDDRA-PT E95 Detachment of retinal pigment epithelium
A343	MEDDRA-PT-ID E95 10052501
A344	CUI E97 C0339546
A345	UMLS-Preferred-Name E97 Retinal Pigment Epithelial Detachment
A346	MEDDRA-PT E97 Detachment of retinal pigment epithelium
A347	MEDDRA-PT-ID E97 10052501
A348	CUI E98 C0339546
A349	UMLS-Preferred-Name E98 Retinal Pigment Epithelial Detachment
A350	MEDDRA-PT E98 Detachment of retinal pigment epithelium
A351	MEDDRA-PT-ID E98 10052501
A352	CUI E99 C0042164
A353	UMLS-Preferred-Name E99 Uveitis
A354	MEDDRA-PT E99 Uveitis
A355	MEDDRA-PT-ID E99 10046851
A356	CUI E100 C0022081
A357	UMLS-Preferred-Name E100 Iritis
A358	MEDDRA-PT E100 Iritis
A359	MEDDRA-PT-ID E100 10022955
A360	CUI E102 C0042164
A361	UMLS-Preferred-Name E102 Uveitis
A362	MEDDRA-PT E102 Uveitis
A363	MEDDRA-PT-ID E102 10046851
A364	CUI E103 C0022081
A365	UMLS-Preferred-Name E103 Iritis
A366	MEDDRA-PT E103 Iritis
A367	MEDDRA-PT-ID E103 10022955
A368	CUI E104 C0042164
A369	UMLS-Preferred-Name E104 Uveitis
A370	MEDDRA-PT E104 Uveitis
A371	MEDDRA-PT-ID E104 10046851
A372	CUI E105 C0235723
A373	UMLS-Preferred-Name E105 Reaction febrile
A374	MEDDRA-PT E105 Pyrexia
A375	MEDDRA-PT-ID E105 10037660
A376	LLT E105 Febrile reaction
A377	LLT-ID E105 10016289
A378	CUI E107 C0015967
A379	UMLS-Preferred-Name E107 Fever
A380	MEDDRA-PT E107 Pyrexia
A381	MEDDRA-PT-ID E107 10037660
A382	LLT E107 Fever
A383	LLT-ID E107 10016558
A384	CUI E108 C0020649
A385	UMLS-Preferred-Name E108 Hypotension
A386	MEDDRA-PT E108 Hypotension
A387	MEDDRA-PT-ID E108 10021097
A388	CUI E109 C0424790
A389	UMLS-Preferred-Name E109 Rigor - Temperature-associated observation
A390	MEDDRA-PT E109 Chills
A391	MEDDRA-PT-ID E109 10008531
A392	LLT E109 Rigors
A393	LLT-ID E109 10039177
A394	CUI E110 C0085593
A395	UMLS-Preferred-Name E110 Chills
A396	MEDDRA-PT E110 Chills
A397	MEDDRA-PT-ID E110 10008531
A398	CUI E111 C0011175
A399	UMLS-Preferred-Name E111 Dehydration
A400	MEDDRA-PT E111 Dehydration
A401	MEDDRA-PT-ID E111 10012174
A402	CUI E112 C0035078
A403	UMLS-Preferred-Name E112 Kidney Failure
A404	MEDDRA-PT E112 Renal failure
A405	MEDDRA-PT-ID E112 10038435
A406	CUI E114 C0015967
A407	UMLS-Preferred-Name E114 Fever
A408	MEDDRA-PT E114 Pyrexia
A409	MEDDRA-PT-ID E114 10037660
A410	LLT E114 Fever
A411	LLT-ID E114 10016558
A412	CUI E117 C0015967
A413	UMLS-Preferred-Name E117 Fever
A414	MEDDRA-PT E117 Pyrexia
A415	MEDDRA-PT-ID E117 10037660
A416	LLT E117 Fever
A417	LLT-ID E117 10016558
A418	CUI E118 C0015967
A419	UMLS-Preferred-Name E118 Fever
A420	MEDDRA-PT E118 Pyrexia
A421	MEDDRA-PT-ID E118 10037660
A422	LLT E118 Fever
A423	LLT-ID E118 10016558
A424	CUI E119 C0235723
A425	UMLS-Preferred-Name E119 Reaction febrile
A426	MEDDRA-PT E119 Pyrexia
A427	MEDDRA-PT-ID E119 10037660
A428	LLT E119 Febrile reaction
A429	LLT-ID E119 10016289
A430	CUI E121 C0015967
A431	UMLS-Preferred-Name E121 Fever
A432	MEDDRA-PT E121 Pyrexia
A433	MEDDRA-PT-ID E121 10037660
A434	LLT E121 Fever
A435	LLT-ID E121 10016558
A436	CUI E122 C0020649
A437	UMLS-Preferred-Name E122 Hypotension
A438	MEDDRA-PT E122 Hypotension
A439	MEDDRA-PT-ID E122 10021097
A440	CUI E123 C0424790
A441	UMLS-Preferred-Name E123 Rigor - Temperature-associated observation
A442	MEDDRA-PT E123 Chills
A443	MEDDRA-PT-ID E123 10008531
A444	LLT E123 Rigors
A445	LLT-ID E123 10039177
A446	CUI E124 C0085593
A447	UMLS-Preferred-Name E124 Chills
A448	MEDDRA-PT E124 Chills
A449	MEDDRA-PT-ID E124 10008531
A450	CUI E125 C0015967
A451	UMLS-Preferred-Name E125 Fever
A452	MEDDRA-PT E125 Pyrexia
A453	MEDDRA-PT-ID E125 10037660
A454	LLT E125 Fever
A455	LLT-ID E125 10016558
A456	CUI E128 C0235723
A457	UMLS-Preferred-Name E128 Reaction febrile
A458	MEDDRA-PT E128 Pyrexia
A459	MEDDRA-PT-ID E128 10037660
A460	LLT E128 Febrile reaction
A461	LLT-ID E128 10016289
A462	CUI E130 C0015967
A463	UMLS-Preferred-Name E130 Fever
A464	MEDDRA-PT E130 Pyrexia
A465	MEDDRA-PT-ID E130 10037660
A466	LLT E130 Fever
A467	LLT-ID E130 10016558
A468	CUI E131 C0020649
A469	UMLS-Preferred-Name E131 Hypotension
A470	MEDDRA-PT E131 Hypotension
A471	MEDDRA-PT-ID E131 10021097
A472	CUI E132 C0424790
A473	UMLS-Preferred-Name E132 Rigor - Temperature-associated observation
A474	MEDDRA-PT E132 Chills
A475	MEDDRA-PT-ID E132 10008531
A476	LLT E132 Rigors
A477	LLT-ID E132 10039177
A478	CUI E133 C0085593
A479	UMLS-Preferred-Name E133 Chills
A480	MEDDRA-PT E133 Chills
A481	MEDDRA-PT-ID E133 10008531
A482	CUI E134 C0015967
A483	UMLS-Preferred-Name E134 Fever
A484	MEDDRA-PT E134 Pyrexia
A485	MEDDRA-PT-ID E134 10037660
A486	LLT E134 Fever
A487	LLT-ID E134 10016558
A488	CUI E135 C0085593
A489	UMLS-Preferred-Name E135 Chills
A490	MEDDRA-PT E135 Chills
A491	MEDDRA-PT-ID E135 10008531
A492	CUI E136 C0424790
A493	UMLS-Preferred-Name E136 Rigor - Temperature-associated observation
A494	MEDDRA-PT E136 Chills
A495	MEDDRA-PT-ID E136 10008531
A496	LLT E136 Rigors
A497	LLT-ID E136 10039177
A498	CUI E137 C0011175
A499	UMLS-Preferred-Name E137 Dehydration
A500	MEDDRA-PT E137 Dehydration
A501	MEDDRA-PT-ID E137 10012174
A502	CUI E138 C0035078
A503	UMLS-Preferred-Name E138 Kidney Failure
A504	MEDDRA-PT E138 Renal failure
A505	MEDDRA-PT-ID E138 10038435
A506	CUI E139 C0039070
A507	UMLS-Preferred-Name E139 Syncope
A508	MEDDRA-PT E139 Syncope
A509	MEDDRA-PT-ID E139 10042772
A510	CUI E140 C0015967
A511	UMLS-Preferred-Name E140 Fever
A512	MEDDRA-PT E140 Pyrexia
A513	MEDDRA-PT-ID E140 10037660
A514	LLT E140 Fever
A515	LLT-ID E140 10016558
A516	CUI E141 C0015967
A517	UMLS-Preferred-Name E141 Fever
A518	MEDDRA-PT E141 Pyrexia
A519	MEDDRA-PT-ID E141 10037660
A520	LLT E141 Fever
A521	LLT-ID E141 10016558
A522	CUI E142 C0015967
A523	UMLS-Preferred-Name E142 Fever
A524	MEDDRA-PT E142 Pyrexia
A525	MEDDRA-PT-ID E142 10037660
A526	CUI E143 C1167791
A527	UMLS-Preferred-Name E143 Skin toxicity
A528	MEDDRA-PT E143 Skin toxicity
A529	MEDDRA-PT-ID E143 10059516
A530	CUI E146 C1167791
A531	UMLS-Preferred-Name E146 Skin toxicity
A532	MEDDRA-PT E146 Skin toxicity
A533	MEDDRA-PT-ID E146 10059516
A534	CUI E147 C1167791
A535	UMLS-Preferred-Name E147 Skin toxicity
A536	MEDDRA-PT E147 Skin toxicity
A537	MEDDRA-PT-ID E147 10059516
A538	CUI E148 C1167791
A539	UMLS-Preferred-Name E148 Skin toxicity
A540	MEDDRA-PT E148 Skin toxicity
A541	MEDDRA-PT-ID E148 10059516
A542	CUI E149 C1167791
A543	UMLS-Preferred-Name E149 Skin toxicity
A544	MEDDRA-PT E149 Skin toxicity
A545	MEDDRA-PT-ID E149 10059516
A546	CUI E150 C0037278
A547	UMLS-Preferred-Name E150 Skin Diseases, Infectious
A548	MEDDRA-PT E150 Skin infection
A549	MEDDRA-PT-ID E150 10040872
A550	CUI E152 C0020456
A551	UMLS-Preferred-Name E152 Hyperglycemia
A552	MEDDRA-PT E152 Hyperglycaemia
A553	MEDDRA-PT-ID E152 10020635
A554	LLT E152 Hyperglycemia
A555	LLT-ID E152 10020639
A556	CUI E154 C0020456
A557	UMLS-Preferred-Name E154 Hyperglycemia
A558	MEDDRA-PT E154 Hyperglycaemia
A559	MEDDRA-PT-ID E154 10020635
A560	LLT E154 Hyperglycemia
A561	LLT-ID E154 10020639
A562	CUI E156 C0020456
A563	UMLS-Preferred-Name E156 Hyperglycemia
A564	MEDDRA-PT E156 Hyperglycaemia
A565	MEDDRA-PT-ID E156 10020635
A566	LLT E156 Hyperglycemia
A567	LLT-ID E156 10020639
A568	CUI E158 C0002878
A569	UMLS-Preferred-Name E158 Anemia, Hemolytic
A570	MEDDRA-PT E158 Haemolytic anaemia
A571	MEDDRA-PT-ID E158 10018916
A572	LLT E158 Hemolytic anemia
A573	LLT-ID E158 10019493
A574	CUI E160 C0854268
A575	UMLS-Preferred-Name E160 Foetal damage
A576	MEDDRA-PT E160 Foetal damage
A577	MEDDRA-PT-ID E160 10016852
A578	LLT E160 Fetal damage
A579	LLT-ID E160 10054743
A580	CUI E162 C0232910
A581	UMLS-Preferred-Name E162 Teratogenesis
A582	MEDDRA-PT E162 Teratogenicity
A583	MEDDRA-PT-ID E162 10043275
A584	CUI E163 C0270009
A585	UMLS-Preferred-Name E163 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A586	MEDDRA-PT E163 Maternal drugs affecting foetus
A587	MEDDRA-PT-ID E163 10026923
A588	LLT E163 Drug toxicity NEC affecting foetus
A589	LLT-ID E163 10013750
A590	CUI E167 C0035305
A591	UMLS-Preferred-Name E167 Retinal Detachment
A592	MEDDRA-PT E167 Retinal detachment
A593	MEDDRA-PT-ID E167 10038848
A594	CUI E168 C0015967
A595	UMLS-Preferred-Name E168 Fever
A596	MEDDRA-PT E168 Pyrexia
A597	MEDDRA-PT-ID E168 10037660
A598	CUI E169 C1519689
A599	UMLS-Preferred-Name E169 Tumor Promotion
A600	MEDDRA-PT E169 Carcinogenicity
A601	MEDDRA-PT-ID E169 10007269
A602	CUI E170 C0019080
A603	UMLS-Preferred-Name E170 Hemorrhage
A604	MEDDRA-PT E170 Haemorrhage
A605	MEDDRA-PT-ID E170 10055798
A606	LLT E170 Hemorrhage
A607	LLT-ID E170 10019524
A608	CUI E171 C1861172
A609	UMLS-Preferred-Name E171 Venous Thromboembolism
A610	MEDDRA-PT E171 Embolism venous
A611	MEDDRA-PT-ID E171 10014522
A612	LLT E171 Venous thromboembolism
A613	LLT-ID E171 10066899
A614	CUI E172 C0235723
A615	UMLS-Preferred-Name E172 Reaction febrile
A616	MEDDRA-PT E172 Pyrexia
A617	MEDDRA-PT-ID E172 10037660
A618	LLT E172 Febrile reaction
A619	LLT-ID E172 10016289
A620	CUI E174 C0270009
A621	UMLS-Preferred-Name E174 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A622	MEDDRA-PT E174 Maternal drugs affecting foetus
A623	MEDDRA-PT-ID E174 10026923
A624	LLT E174 Drug toxicity NEC affecting foetus
A625	LLT-ID E174 10013750
